Annual Information Update

RNS Number : 6737X

The MedicX Fund Limited

17 February 2012

 



For immediate release                                                                                    

17 February 2012

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Annual Information Update

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom, today announces that in accordance with Prospectus Rule 5.2 the following information has been published or made available to the public in compliance with laws and rules dealing with the regulation of securities.

The information referred to in this update was up-to-date at the time of publication but some information may now be out-of-date. The Annual Report and Financial Statements for the year to 30 September 2011 were published on 18 January 2012. The preliminary results announcement was issued on 8 December 2011.

1. Announcements made via RNS, a regulatory information service

Date	Brief description of announcement
9 February 2012	Completion of new debt facility
30 January 2012	Prospectus Published
26 January 2012	AGM and Annual Report
25 January 2012	Notice of dividend
20 January 2012	Interim Management Statement
19 January 2012	Notification of major interest in shares
3 January 2012	Total Voting Rights
3 January 2012	Allotment of shares to investment adviser
3 January 2012	Allotment of shares to directors
22 December 2011	Issue of new ordinary shares
22 December 2011	Acquisition of new primary medical centre
21 December 2011	Acquisition of new primary medical centre
14 December 2011	Additional Listing
8 December 2011	Proposed dividend for year ended 30 September 2012
8 December 2011	Amendment to Investment Adviser fee structure
8 December 2011	Results for the year ended 30 September 2011
23 November 2011	Scrip Calculator Price
22 November 2011	Scrip Dividend Circular
15 November 2011	Block listing six monthly return
10 November 2011	Quarterly NAV and Dividend Announcement
7 November 2011	Transfer of shares held by Director
3 October 2011	Allocation to Directors
3 October 2011	Total Voting Rights
3 October 2011	Allocation to Investment Adviser
29 September 2011	Additional Listing
27 September 2011	Acquisition of new primary care medical centre
24 August 2011	Scrip Calculation Price
23 August 2011	Circular to Shareholders - Scrip Dividend Scheme
10 August 2011	Acquisition of new primary care medical centre
10 August 2011	Acquisition of new primary care medical centre
5 August 2011	Interim Management Statement
2 August 2011	Notice of dividend
1 August 2011	Total Voting Rights
26 July 2011	Acquisition
7 July 2011	Issue of new ordinary shares
4 July 2011	Total Voting Rights
4 July 2011	Allotment of scrip shares to Investment Adviser
4 July 2011	Allotment of scrip shares to Directors
28 June 2011	Additional Listing
20 June 2011	Total voting rights
20 June 2011	Issue of new ordinary shares
20 June 2011	Rochdale Acquisition
26 May 2011	Results for the six months to 31 March 2011
25 May 2011	Scrip Calculation Price
24 May 2011	Circular to Shareholders - Scrip Dividend Scheme
24 May 2011	Notification of Major Interest in Shares
12 May 2011	Block listing six monthly return
12 May 2011	Quarterly Net Asset Value
4 May 2011	Notice of dividend
4 April 2011	Notification of Major Interest in Shares
1 April 2011	Total voting rights
1 April 2011	Allotment of scrip shares
30 March 2011	Approved acquisitions
17 March 2011	Notification of major interest in shares
14 March 2011	Director Declaration
14 March 2011	Notification of major interest in shares
8 March 2011	Notification of major interest in shares
3 March 2011	Notification of major interest in shares
2 March 2011	Results of Issue
25 February 2011	Placing / Open Offer / Offer for Subscription
24 February 2011	Result of EGM
24 February 2011	Result of AGM
23 February 2011	Scrip Dividend Calculation Price
22 February 2011	Circular to Shareholders - Scrip Dividend Scheme
22 February 2011	Acquisition of new primary care medical centre
15 February 2011	Notice of quarterly dividend
15 February 2011	Annual Information Update

Details of all regulatory announcements can be found in full on the London Stock Exchange's website at www.londonstockexchange.com using the code MXF or on the Company's website at www.medicxfund.com.

2. Company Reports

Copies of all the Company Reports listed below are available from International Administration Guernsey, Regency Court, Glategny Esplanade, St Peter Port, Guernsey.

Date	Company Reports
18 January 2012	Annual Report and Financial Statements 2011
11 July 2011	Interim Report 2011
27 January 2011	Annual Report and Financial Statements 2010

3. Documents filed at the Guernsey Company Registry

All of the documents listed below were filed with the Registrar of Companies in Guernsey on or around the dates indicated.

Date	Company Reports	Reference
25 January 2012	AV Amendment	402851
16 January 2012	AV Financial product Companies	395203
23 March 2011	Resolution - Variation of Class Rights Approval	350134
23 March 2011	Resolution - Authority to Acquire Shares	350133
22 March 2011	Resolution - Authority to Acquire Shares	350032

Copies of these documents can be obtained on the Guernsey Registry website at www.greg.gg.

4. Documents submitted to the UK Listing Authority and sent to shareholders

All of the documents listed below were submitted to the National Storage Mechanism and are available at http://www.hemscott.com/nsm.do.

Date	Brief description of document
30 January 2012	Prospectus
13 January 2012	AGM letter, notice and proxy 2012
22 November 2011	Letter regarding December 2011 Dividend - Shareholder circular
30 September 2011	Annual Report 2011
23 August 2011	Scrip Dividend 2011 Letter - Shareholder Circular
24 May 2011 31 March 2011	Scrip Dividend Letter re June 2011 dividend - Shareholder circular Interim Report 2011
22 February 2011	Letter regarding March 2011 Dividend

Copies of the above documents are also available from International Administration Guernsey, Regency Court, Glategny Esplanade, St Peter Port, Guernsey. 

- End -

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund                                                                  [phone]

David Staples, Chairman

Buchanan Communications                                              [phone]

Charles Ryland/Suzanne Brocks

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 65 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 26 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

AIULLFVRFLIDLIF